Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vehreschild

Showing results (111-120 of 221) with videos related to

Pageof 23
Sort By:
Haematologica|August 24, 2011
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patientsMaria J G T Vehreschild, Arne M K Meissner, Oliver Andreas Cornely, et al.
Gut Microbes|August 18, 2018
Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of ClostridialesFedja Farowski, Gregor Els, Anastasia Tsakmaklis, et al.
Scientific Reports|June 12, 2020
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive toolsSonja Lang, Fedja Farowski, Anna Martin, et al.
Nature Communications|April 15, 2021
Microbiota-based markers predictive of development of Clostridioides difficile infectionMatilda Berkell, Mohamed Mysara, Basil Britto Xavier, et al.
European Journal of Haematology|May 2, 2021
Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centersFelix Goeser, Barbara Sifft, Christoph Stein-Thoeringer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2023
Clinical characteristics and outcome of Mycobacterium chimaera infections after cardiac surgery: systematic review and meta-analysis of 180 heater-cooler unit-associated casesNils Wetzstein, Thomas A Kohl, Margo Diricks, et al.
Infection|August 9, 2013
Evaluation of an infectious disease consultation programme in a German tertiary care hospitalJ J Vehreschild, G Morgen, O A Cornely, et al.
BMC Cancer|November 29, 2023
TIGIT<sup>+</sup> NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patientsAnastasia Tsakmaklis, Fedja Farowski, Rafael Zenner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2022
Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)Sebastian M Wingen-Heimann, Kerrie Davies, Virginie F Viprey, et al.
International Journal of Antimicrobial Agents|December 16, 2011
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trialJ Janne Vehreschild, Gregor Moritz, Maria J G T Vehreschild, et al.
Pageof 23

Showing results (111-120 of 221) with videos related to

Sort By:
Pageof 23
Haematologica|August 24, 2011
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patientsMaria J G T Vehreschild, Arne M K Meissner, Oliver Andreas Cornely, et al.
Gut Microbes|August 18, 2018
Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of ClostridialesFedja Farowski, Gregor Els, Anastasia Tsakmaklis, et al.
Scientific Reports|June 12, 2020
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive toolsSonja Lang, Fedja Farowski, Anna Martin, et al.
Nature Communications|April 15, 2021
Microbiota-based markers predictive of development of Clostridioides difficile infectionMatilda Berkell, Mohamed Mysara, Basil Britto Xavier, et al.
European Journal of Haematology|May 2, 2021
Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centersFelix Goeser, Barbara Sifft, Christoph Stein-Thoeringer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2023
Clinical characteristics and outcome of Mycobacterium chimaera infections after cardiac surgery: systematic review and meta-analysis of 180 heater-cooler unit-associated casesNils Wetzstein, Thomas A Kohl, Margo Diricks, et al.
Infection|August 9, 2013
Evaluation of an infectious disease consultation programme in a German tertiary care hospitalJ J Vehreschild, G Morgen, O A Cornely, et al.
BMC Cancer|November 29, 2023
TIGIT<sup>+</sup> NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patientsAnastasia Tsakmaklis, Fedja Farowski, Rafael Zenner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2022
Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)Sebastian M Wingen-Heimann, Kerrie Davies, Virginie F Viprey, et al.
International Journal of Antimicrobial Agents|December 16, 2011
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trialJ Janne Vehreschild, Gregor Moritz, Maria J G T Vehreschild, et al.
Pageof 23